Fahad Ba Mehriz, Consultant Laparoscopic and Bariatric1, Hassan Arishi, General Surgery Resident2, Mohammed Alali, General Surgery Resident1. 1King Khalid university hospital, 2King Abdulaziz Medical City, National guard health affair
Background: Morbidly obese patients with associated co-morbidities have high perioperative morbidity and mortality. Cardiomyopathy found to be a predictor for mortality in those undergoing bariatric surgery. Laparoscopic sleeve gastrectomy (LSG) with its low complications rate could be safe option for those patients.
Methods: A retrospective study of morbidly obese patients with cardiomyopathy underwent LSG (2016-2018). Length of stay, 30-day morbidity, mortality, and emergency department visits were assessed. The aim is to assess the feasibility and safety of LSG in morbidly obese patients with cardiomyopathy.
Results: Elven patients (7 men) with mean age 41.27 +/- 5.16 years, preoperative body mass index (BMI) 52.78 +/- 4 Kg/m2 (39-88), and mean ejection fraction 38.73% (20.3-73.9). Six patients (54.5%) were having American Society of Anesthesiologists (ASA) class III. The mean length of stay was 5.6 days. There was no 30-day mortality. One patient was re-admitted due to sever dehydration and acute kidney injury.
Conclusion: Our study showed that LSG is feasible and safe for morbidly obese patients with cardiomyopathy. Further researches are recommended to assess postoperative ventricular function and quality of life.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 95878
Program Number: P126
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster